作者: Maik J. Grundeken , Robbert J. de Winter , Joanna J. Wykrzykowska
DOI: 10.1080/17434440.2017.1338135
关键词:
摘要: ABSTRACTIntroduction: Percutaneous coronary interventions (PCIs) involving bifurcation lesions are associated with adverse outcomes compared non-bifurcation lesions. The Tryton Side Branch Stent has been developed to improve clinical after PCI.Areas covered: We will discuss observational data (clinical registries and intravascular imaging studies) randomized from the TRYTON trial (comparing [used in combination a main branch drug-eluting stent (DES)] side balloon angioplasty [in DES; also referred provisional strategy]).Expert commentary: published showed that use of was feasible (successful placement ~95%) safe (stent thrombosis rates ~0.5% at 9–12 months; no cardiac deaths trial). Its resulted excellent acute angiographic results. However, due neo-intimal tissue growth, luminal dimension 9 months were simil...